Crescent Capital BDC (CCAP) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Crescent Capital BDC

NasdaqGM•Financial Services•Asset Management

$10.37-0.08(-0.01%)Market closed

Market Cap

$365.60M

P/S

2.3x

P/B

0.6x

Crescent Capital BDC, Inc. is as a business development company is a private debt fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

How this company scores

WeakMetricSide Score: 34/100

Strongest: Cash & Earnings Quality (13/25); weakest: Growth (3/25).

Profitability8/25

Growth3/25

Balance Sheet & Red Flags10/25

Cash & Earnings Quality13/25

Strengths

Long cash runwayCash-backed earningsNo share dilution

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 30.4x5y range 6.1x – 30.4x

Currently above its 12-quarter median.

P/S · 2.3x5y range 2.3x – 3.7x

Currently below its 13-quarter median.

P/B · 0.6x5y range 0.6x – 1.0x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Watch

FCF/Net Income has dropped below 0.7x in 3 quarters — monitor for earnings quality deterioration.

Price & Volume

Market Cap $365.60M

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $156.40M
Q. Revenue: $36.32M
TTM EBITDA: $-92.56M
TTM Op. Income: $-92.56M
Q. Op. Income: $-22.72M
TTM Net Income: $-3.17M
Q. Net Income: $-3.25M
EPS: $-0.09
Shares Out.: $36.85M

$156.40M in TTM revenue declined 14.6% YoY, reaching $36.32M last quarter. TTM EBITDA of $-92.56M and TTM operating income of $-92.56M show growth is flowing through to the bottom line. However, net income is negative at $3.17M — growth is not yet reaching the bottom line. Across the last 8 quarters, TTM revenue has fallen for 7 consecutive quarters — a weakening trend.

Margins

Gross, EBITDA, operating, and net margin trends

EBITDA Margin: -62.5%
Op. Margin: -62.5%
Net Margin: -8.9%

Op. margin of -62.5% is down 2.8% YoY — costs are rising relative to revenue. Net margin at -8.9% Over the past year, operating margin is down 5% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: N/A
P/S Ratio: 2.3x
P/B Ratio: 0.6x

P/S of 2.3x and P/B of 0.6x. Across the last 7 quarters, P/E has risen for 3 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.62B
Cash: $15.60M
Long-Term Debt: $922.95M
Book Value: $656.45M
D/E Ratio: 1.4
Debt/EBITDA: N/A

With $1.62B in assets and $922.95M in long-term debt, D/E is 1.4and book value is $656.45M — moderate leverage. Across the last 8 quarters, debt/equity has risen for 4 consecutive quarters — a weakening trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $9.85M
TTM Free Cash Flow: $39.47M
FCF Margin: 25.2%
FCF / Net Income: -12.5

TTM FCF of $39.47M on $9.85M in operating cash flow. The FCF / Net Income ratio of -12.5x means the business consumes cash — it is not yet self-funding. Across the last 8 quarters, free cash flow has fallen for 2 consecutive quarters — a weakening trend.